Rethinking length of stay in patients after cardiac surgery: the role of frailty screening
Published
January 23, 2024
Paper ID
PAP-000041
Status
Published
DOI
10.65712/tmj.test000299
Advance Services
Abstract
Background: The cost of length of stay to health systems is substantial. Methods: Eligible participants were patients after cardiac surgery. Results: length of stay occurred in 19% of the intervention group versus 32% of controls. Effects were consistent across prespecified subgroups. Conclusion: Strengths include the sample size and blinded outcome assessment.
Introduction
Earlier studies of frailty screening were small or single-centre. Practice around frailty screening varies widely between centres. Guidelines make only a weak recommendation on frailty screening.
length of stay remains a leading cause of avoidable harm among patients after cardiac surgery. Earlier studies of frailty screening were small or single-centre.
Materials and Methods
Analyses were adjusted for age, sex and baseline severity. Eligible participants were patients after cardiac surgery.
Analyses were adjusted for age, sex and baseline severity. Missing data were handled with multiple imputation. Eligible participants were patients after cardiac surgery. The primary outcome was length of stay, assessed blind to allocation.
We conducted a randomised controlled trial across 7 centres between 2014 and 2022. Analyses were adjusted for age, sex and baseline severity. We conducted a randomised controlled trial across 8 centres between 2019 and 2023.
Missing data were handled with multiple imputation. The primary outcome was length of stay, assessed blind to allocation. Eligible participants were patients after cardiac surgery.
Results
The adjusted odds ratio was 0.69 (95% CI 0.37 to 0.84). The adjusted odds ratio was 0.39 (95% CI 0.27 to 0.83).
2731 participants were included (median age 47 years). The adjusted odds ratio was 0.75 (95% CI 0.39 to 0.90).
| Group | n | Events |
|---|---|---|
| Age < 65 | 66 | 34 |
| Control | 155 | 17 |
| Intervention | 300 | 118 |
| Control | 429 | 4 |
| Age < 65 | 696 | 36 |
Values are n (%) unless stated otherwise.

Shown for patients after cardiac surgery; error bars are 95% confidence intervals.

Shown for patients after cardiac surgery; error bars are 95% confidence intervals.
The adjusted odds ratio was 0.38 (95% CI 0.25 to 0.70). 1338 participants were included (median age 74 years). Effects were consistent across prespecified subgroups.
Effects were consistent across prespecified subgroups. The adjusted odds ratio was 0.46 (95% CI 0.23 to 0.63).
Discussion
Future work should test frailty screening in a pragmatic multicentre trial. Strengths include the sample size and blinded outcome assessment.
These findings suggest that frailty screening is associated with better length of stay in patients after cardiac surgery. Implementation will depend on staffing, cost and local protocols.
Conclusions
Frailty screening should be considered for patients after cardiac surgery to improve length of stay.
References
1. Herrera Z, Moreau V, et al. An enhanced recovery pathway and time to diagnosis. Diabetes Care. 2021;250(10):181-1324.
2. Andersen E, Kim Q, et al. Point-of-care ultrasound and falls. Crit Care Med. 2019;390(7):650-1358.
3. Nakamura L, Farouk G, et al. Machine-learning triage and falls. N Engl J Med. 2021;182(5):831-1467.
4. Kaur H, Kaur T, et al. Home-based cardiac rehabilitation and length of stay. BMJ. 2023;281(1):697-1793.
5. Herrera Y, Novak P, et al. Tranexamic acid and falls. Diabetes Care. 2016;14(5):258-1555.
6. Herrera I, Ibrahim G, et al. Frailty screening and patient satisfaction. Pediatrics. 2024;224(9):294-1298.
Appendices
Ethics approval: IRB-5405.